Bluejay Diagnostics Inc

NASDAQ:BJDX   3:55:30 PM EDT
0.65
-0.02 (-2.98%)
4:29:47 PM EDT: $0.65 0.00 (0.75%)
Earnings Announcements

Bluejay Diagnostics Inc Reports Quarterly Loss Per Share Of $0.15

Published: 11/08/2022 23:44 GMT
Bluejay Diagnostics Inc (BJDX) - Bluejay Diagnostics Inc - Cash and Cash Equivalents on September 30, 2022 Were $13.3 Million, As Compared to $19.0 Million on December 31, 2021.
Bluejay Diagnostics Inc- Qtrly Loss per Share $0.15.
Further Company Coverage: Bjdxo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.04

Next Quarter Revenue Guidance is expected to be $0.81 Million
Next Quarter EPS Guidance is expected to be -$0.06

More details on our Analysts Page.